|
|
DSpace at RU >
Search Results
Results 1-50 of 67.
Item hits:
| Full Text | Issue Date | Title | Author(s) |  | 2011 | Differences in T cell depletion and intestinal mucositis explain inconsistent effects of NOD2/CARD15 polymophisms in SCT | Velden, W.J.F.M. van der; Donnelly, J.P.; Blijlevens, N.M.A. |
| | 2011 | Issues in genetic association studies: limitations of statistical analysis and biological plausibility | Velden, W.J.F.M. van der; Feuth, T.; Stevens, W.B.C.; Donnelly, J.P.; Blijlevens, N.M.A. |
| | 2011 | Detecteren van koorts bij de hematologische patiënt in de neutropene fase. [Detection of fever in the neutropenic period of the haematological patient] | Ploos van Amstel, F.K.; Vliet, M. van; Potting, C.M.J.; Donnelly, P.; Blijlevens, N.M.A.; Schoonhoven, L. |
| | 2011 | Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients. | Pagano, L.; Akova, M.; Dimopoulos, G.; Herbrecht, R.; Drgona, L.; Blijlevens, N.M.A. |
| | 2011 | Performance of the new Platelia Candida Plus assays for the diagnosis of invasive Candida infection in patients undergoing myeloablative therapy | Lunel, F.M.; Donnelly, J.P.; Lee, H.A.L. van der; Blijlevens, N.M.A.; Verweij, P.E. |
| | 2011 | Adult metachromatic leukodystrophy treated by allo-SCT and a review of the literature | Hosson, L.D. de; Warrenburg, B.P.C. van de; Preijers, F.W.M.B.; Blijlevens, N.M.A.; Reijden, B.A. van der; Kremer, H.P.H.; Lefeber, D.J.; Allebes, W.A.; Al-Ali, H.; Niederwieser, D.W.; Schaap, N.P.M.; Schattenberg, A.V.M.B. |
 | 2011 | How prompt is prompt in daily practice? Earlier initiation of empirical antibacterial therapy for the febrile neutropenic patient | Vliet, M. van; Potting, C.M.J.; Sturm, P.D.J.; Donnelly, J.P.; Blijlevens, N.M.A. |
| | 2011 | Polymorphisms in CCR6 are associated with chronic graft-versus-host disease and invasive fungal disease in matched-related hematopoietic stem cell transplantation | Broen, K.C.J.; Waart, A.B. van der; Greupink-Draaisma, A.L.; Metzig, J.; Feuth, T.; Schaap, N.P.M.; Blijlevens, N.M.A.; Velden, W.J. van der; Dolstra, H. |
| | 2011 | Genetic variants and the risk for invasive mould disease in immunocompromised hematology patients | Velden, W.J.F.M. van der; Blijlevens, N.M.A.; Donnelly, J.P. |
| | 2011 | The Y238X stop codon polymorphism in the human beta-glucan receptor dectin-1 and susceptibility to invasive aspergillosis | Chai, L.; Boer, M.G. de; Velden, W.J. van der; Plantinga, T.S.; Spriel, A.B. van; Jacobs, C.W.; Halkes, C.J.; Vonk, A.G.; Blijlevens, N.M.A.; Dissel, J.T. van; Donnelly, P.; Kullberg, B.J.; Maertens, J.; Netea, M.G. |
| | 2010 | Host-microbe interactions in stem cell transplantation: recognizing Candida in infection and inflammation. | Velden, W.J.F.M. van der; Plantinga, T.S.; Donnelly, J.P.; Kullberg, B.J.; Blijlevens, N.M.A.; Netea, M.G. |
| | 2010 | The incidence of acute graft-versus-host disease increases with Candida colonization depending the dectin-1 gene status. | Velden, W.J.F.M. van der; Plantinga, T.S.; Feuth, T.; Donnelly, J.P.; Netea, M.G.; Blijlevens, N.M.A. |
| | 2010 | Citrulline-based assessment score: first choice for measuring and monitoring intestinal failure after high-dose chemotherapy. | Herbers, A.H.E.; Feuth, T.; Donnelly, J.P.; Blijlevens, N.M.A. |
 | 2010 | Intestinal damage determines the inflammatory response and early complications in patients receiving conditioning for a stem cell transplantation. | Velden, W.J.F.M. van der; Herbers, A.H.E.; Feuth, T.; Schaap, N.P.M.; Donnelly, J.P.; Blijlevens, N.M.A. |
| | 2010 | Pharmacokinetics and safety of 14 days intravenous voriconazole in allogeneic haematopoietic stem cell transplant recipients. | Bruggemann, R.J.M.; Blijlevens, N.M.A.; Burger, D.M.; Franke, B.; Troke, P.F.; Donnelly, J.P. |
| | 2009 | Neutropenic enterocolitis: challenges in diagnosis and treatment. | Blijlevens, N.M.A. |
| | 2009 | Palifermin in allogeneic HSCT: many questions remain. | Velden, W.J.F.M. van der; Herbers, A.H.E.; Blijlevens, N.M.A. |
| | 2009 | The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Mucositis: from febrile neutropenia to febrile mucositis. | Blijlevens, N.M.A.; Logan, A.; Netea, M.G. |
| | 2009 | Misleading one-stage coagulation factor assay during rFVIIa treatment in lupus patient. | Herbers, A.H.E.; Verbruggen, H.W.; Veerdonk, F.L. van de; Kraaij, M.G.J. van; Blijlevens, N.M.A.; Novakova, I.R.O. |
| | 2009 | Value of Candida serum markers in patients with invasive candidiasis after myeloablative chemotherapy. | Lunel, F.M.; Mennink-Kersten, M.A.S.H.; Ruegebrink, D.; Lee, H.A.L. van der; Donnelly, J.P.; Blijlevens, N.M.A.; Verweij, P.E. |
| | 2009 | Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agents. | Bruggemann, R.J.M.; Alffenaar, J.W.C.; Blijlevens, N.M.A.; Billaud, E.M.; Kosterink, J.G.W.; Verweij, P.E.; Burger, D.M. |
| | 2009 | A review of quality assessment of the methodology used in guidelines and systematic reviews on oral mucositis. | Potting, C.M.J.; Mistiaen, P.; Poot, E.; Blijlevens, N.M.A.; Donnelly, P.; Achterberg, T. van |
| | 2009 | Safety and tolerability of the antimicrobial peptide human lactoferrin 1-11 (hLF1-11). | Velden, W.J.F.M. van der; Iersel, T.M. van; Blijlevens, N.M.A.; Donnelly, J.P. |
| | 2009 | The Prospective Oral Mucositis Audit: relationship of severe oral mucositis with clinical and medical resource use outcomes in patients receiving high-dose melphalan or BEAM-conditioning chemotherapy and autologous SCT. | McCann, S.; Schwenkglenks, M.; Bacon, P.; Einsele, H.; D'Addio, A.; Maertens, J.; Niederwieser, D.; Rabitsch, W.; Roosaar, A.; Ruutu, T.; Schouten, H.; Stone, R.; Vorkurka, S.; Quinn, B.; Blijlevens, N.M.A. |
| | 2009 | Febrile mucositis in haematopoietic SCT recipients. | Velden, W.J.F.M. van der; Blijlevens, N.M.A.; Feuth, A.B.; Donnelly, J.P. |
| | 2009 | Plasma citrulline measurement using UPLC tandem mass-spectrometry to determine small intestinal enterocyte pathology. | Demacker, P.N.M.; Beijers, A.M.; Daal, H. van; Donnelly, J.P.; Blijlevens, N.M.A.; Ouweland, J.M.W. van den |
| | 2009 | Loss of enterocyte mass is accompanied by diminished turnover of enterocytes after myeloablative therapy in haematopoietic stem-cell transplant recipients. | Derikx, J.P.; Blijlevens, N.M.A.; Donnelly, J.P.; Fujii, H.; Kanda, T.; Bijnen, A.A. van; Heineman, E.; Buurman, W.A. |
| | 2009 | Circulating Candida-specific anti-mannan antibodies precede invasive candidiasis in patients undergoing myelo-ablative chemotherapy. | Verduyn Lunel, F.M.; Donnelly, J.P.; Lee, H.A.L. van der; Blijlevens, N.M.A.; Verweij, P.E. |
| | 2009 | NOD2 polymorphisms predict severe acute graft-versus-host and treatment-related mortality in T-cell-depleted haematopoietic stem cell transplantation. | Velden, W.J.F.M. van der; Blijlevens, N.M.A.; Maas, F.M.H.M.; Schaap, N.P.M.; Jansen, J.H.; Reijden, B.A. van der; Feuth, A.B.; Dolstra, H.; Donnelly, J.P. |
| | 2009 | Early stop polymorphism in human DECTIN-1 is associated with increased candida colonization in hematopoietic stem cell transplant recipients. | Plantinga, T.S.; Velden, W.J.F.M. van der; Ferwerda, E.B.; Spriel, A.B. van; Adema, G.J.; Feuth, A.B.; Donnelly, J.P.; Brown, G.D.; Kullberg, B.J.; Blijlevens, N.M.A.; Netea, M.G. |
| | 2008 | Palifermine voor mucositis bij stamceltransplantatie patienten | Herbers, A.H.E.; Blijlevens, N.M.A. |
| | 2008 | Invasieve zygomycose bij patiënten die worden behandeld voor een hematologische maligniteit | Verweij, P.E.; Velden, W.J.F.M. van der; Donnelly, P.; Blijlevens, N.M.A.; Warris, A. |
| | 2008 | Pharmacokinetic drug interactions of azoles. | Bruggemann, R.J.M.; Alffenaar, J.W.C.; Blijlevens, N.M.A.; Billaud, E.M.; Kosterink, J.G.W.; Verweij, P.E.; Burger, D.M. |
| | 2008 | Guidelines for the assessment of oral mucositis in adult chemotherapy, radiotherapy and haematopoietic stem cell transplant patients. | Quinn, B.; Potting, C.M.J.; Stone, R.; Blijlevens, N.M.A.; Fliedner, M.; Margulies, A.; Sharp, L. |
| | 2008 | Providing oral care in haematological oncology patients: nurses' knowledge and skills. | Potting, C.M.J.; Mank, A.; Blijlevens, N.M.A.; Donnelly, J.P.; Achterberg, T. van |
| | 2008 | Emericella quadrilineata as cause of invasive aspergillosis. | Verweij, P.E.; Varga, J.; Houbraken, J.; Rijs, A.J.M.M.; Verduynlunel, F.M.; Blijlevens, N.M.A.; Shea, Y.R.; Holland, S.M.; Warris, A.; Melchers, W.J.G.; Samson, R.A. |
| | 2008 | Palifermin-induced flexural hyperpigmentation: a clinical and histological study of five cases. | Sibelt, L.A.G.; Aboosy, N.; Velden, W.J.F.M. van der; Blijlevens, N.M.A.; Blokx, W.A.M.; Seyger, M.M.B. |
| | 2008 | Bacteraemia coincides with low citrulline concentrations after high-dose melphalan in autologous HSCT recipients. | Herbers, A.H.E.; Blijlevens, N.M.A.; Donnelly, J.P.; Witte, T.J.M. de |
| | 2008 | Improved detection of circulating Aspergillus antigen by use of a modified pretreatment procedure. | Mennink-Kersten, M.A.S.H.; Ruegebrink, D.; Klont, R.R.; Warris, A.; Blijlevens, N.M.A.; Donnelly, J.P.; Verweij, P.E. |
| | 2008 | The potential role of lactoferrin and derivatives in the management of infectious and inflammatory complications of hematology patients receiving a hematopoietic stem cell transplantation. | Velden, W.J.F.M. van der; Blijlevens, N.M.A.; Donnelly, J.P. |
| | 2008 | Therapeutic drug monitoring of voriconazole. | Bruggemann, R.J.M.; Donnelly, J.P.; Aarnoutse, R.E.; Warris, A.; Blijlevens, N.M.A.; Mouton, J.W.; Verweij, P.E.; Burger, D.M. |
| | 2007 | [Invasive zygomycosis in patients treated for haematological malignancies] | Verweij, P.E.; Velden, W.J.F.M. van der; Donnelly, J.P.; Blijlevens, N.M.A.; Warris, A. |
| | 2007 | Ensuring accurate oral mucositis assessment in the European Group for Blood and Marrow Transplantation Prospective Oral Mucositis Audit. | Quinn, B.; Stone, R.; Uhlenhopp, M.; McCann, S.; Blijlevens, N.M.A. |
| | 2007 | Palifermin (recombinant keratinocyte growth factor-1): a pleiotropic growth factor with multiple biological activities in preventing chemotherapy- and radiotherapy-induced mucositis. | Blijlevens, N.M.A.; Sonis, S.T. |
| | 2007 | Determining mucosal barrier injury to the oesophagus using CT scan. | Blijlevens, N.M.A.; Donnelly, J.P.; Yakar, D.; Die, C.E. van; Witte, T.J.M. de |
| | 2006 | Posaconazol (Noxafil). | Dawood, L.; Burger, D.M.; Blijlevens, N.M.A.; Donnelly, J.P. |
| | 2006 | Paradoxical increase in circulating Aspergillus antigen during treatment with caspofungin in a patient with pulmonary aspergillosis. | Klont, R.R.; Mennink-Kersten, M.A.S.H.; Ruegebrink, D.; Rijs, A.J.M.M.; Blijlevens, N.M.A.; Donnelly, J.P.; Verweij, P.E. |
| | 2006 | Successful treatment of liposomal amphotericin B refractory Candida glabrata fungaemia in a patient undergoing a stem cell transplantation. | Veldman, B.A.J.; Verweij, P.E.; Blijlevens, N.M.A. |
| | 2006 | Primary hepatic invasive aspergillosis with progression after rituximab therapy for a post transplantation lymphoproliferative disorder. | Velden, W.J.F.M. van der; Blijlevens, N.M.A.; Klont, R.R.; Donnelly, J.P.; Verweij, P.E. |
| | 2006 | A scoring system for the assessment of oral mucositis in daily nursing practice. | Potting, C.M.J.; Blijlevens, N.M.A.; Donnelly, J.P.; Feuth, A.B.; Achterberg, T. van |
1
2
next
|
